Trulieve Cannabis is trading at $9.58 (+5.16%) alongside a broader U.S. stock-market rally following cooler-than-expected July producer inflation and reduced expectations for near-term Federal Reserve rate hikes.
- No new company-specific announcement was identified on August 13, 2026.
- The latest major catalyst was the August 7 earnings release, reporting $271 million in revenue, 60% gross margin, and $0.11 adjusted EPS.
- Consumer staples and major indexes also advanced; the move appears primarily macro-driven.